Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256827 · ClinicalTrials.gov registry record
Seven Year Update of Macular Degeneration Patients
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 65
- Enrollment target
NCT01256827: Completed study, sponsored by University of California, San Francisco.
NCT01256827 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256827 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose is to assess long term vision outcomes and disease status in patients with age-related macular degeneration previously treated with ranibizumab as participants in the Phase 3 ANCHOR and MARINA Studies and the HORIZON Study.
Primary Outcome
percentage of study eyes with vision of 20/70 or better (ETDRS best-corrected vision with Snellen equivalent)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-04 |
What the finished NCT01256827 record still lists
NCT01256827 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01256827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01256827 about?
NCT01256827 is a clinical study titled "Seven Year Update of Macular Degeneration Patients". The purpose is to assess long term vision outcomes and disease status in patients with age-related macular degeneration previously treated with ranibizumab as participants in the Phase 3 ANCHOR and MARINA Studies and the HORIZON Study.
What is the current status of trial NCT01256827?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2010-12. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01256827?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia